KUALA LUMPUR (Oct 2): Sunzen Biotech Bhd (KL:SUNZEN) said on Wednesday that it has identified another potential target for acquisition that could help accelerate growth of the company, which mainly makes supplements.
A potential target is a local company in the finance industry, according to Sunzen executive chairman Ching Chee Pun. A deal could be reached by next year, which could complement its businesses that also include providing loans to small and medium enterprises (SMEs), he said.
Acquisitions would offer “a faster growth path compared to organic growth,” Ching said. “Therefore, if we identify a suitable target, we are prepared to move forward with an acquisition.”
Ching was speaking at a press briefing on the acquisition of a 70% stake in Eye Nation Medical Sdn Bhd that sells ophthalmic products.
